Dren Bio Stock

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Sign up today and learn more about Dren Bio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Dren Bio Stock

Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.

Funding History

July 2019$5.1M
October 2020$60.0M
March 2022$62.5M

Management

CEO and Co-Fonder

Nenad Tomasevic

Co-Founder, CFO

John Wesley

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo